Argent BioPharma (MXC) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock MXC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Transformative journey driving Argent BioPharma’s growth and US listing plansSeptember 3, 2025 | msn.comUS in vivo study shows Argent’s ArtemiC effective in viral inflammatory modelAugust 24, 2025 | msn.comRunners of the Week: Kaili, Magnetite Mines, Argent Biopharma, OctavaAugust 22, 2025 | msn.comArgent BioPharma Expands with Strategic Acquisition of AusCann AssetsAugust 19, 2025 | msn.comArgent starts EU-GMP cannabinoid supply for drug resistant epilepsy at Slovenia’s largest hospitalJuly 8, 2025 | msn.comArgent and AusCann partner to accelerate cannabinoid pharma developmentApril 15, 2025 | msn.comArgent BioPharma Prepares for Major Capital RaisingJanuary 2, 2025 | tipranks.comArgent BioPharma to Delist From London Stock Exchange, Mulls U.S. ListingNovember 29, 2024 | marketwatch.comArgent BioPharma Ltd (RGT)May 9, 2024 | investing.comArgent BioPharma starts trading on OTCQB Venture Market; appoints CFOMay 6, 2024 | au.investing.comArgent BioPharma appoints Dr Shlomo Sadoun to advisory boardApril 14, 2024 | au.investing.comMGC Pharmaceuticals Ltd (MXC)January 30, 2024 | uk.investing.comMGC Pharmaceuticals raising additional US$500,000 via private placementDecember 21, 2023 | au.investing.comMGC Pharmaceuticals Ltd MXCDecember 20, 2023 | morningstar.comMMGC Pharma receives Saudi approval for ArtemiCDecember 19, 2023 | au.investing.comMGC Pharmaceuticals granted Saudi FDA approval for ArtemiC™December 18, 2023 | au.investing.com‘Fully funded’ – MGC Pharma completes share consolidation and ~US$8 million cap raiseNovember 9, 2023 | msn.comMGC Pharma completes share placing and consolidationNovember 8, 2023 | proactiveinvestors.com.auMGC Pharmaceuticals clarifies share consolidation and new fundraiseNovember 1, 2023 | proactiveinvestors.com.au‘Unwavering Support’: MGC Pharma secures US$7.9 million from investors as looks to advance US FDA IND applicationsNovember 1, 2023 | msn.comMGC Pharmaceuticals to raise US$7.9 million to fund its...MGC Pharmaceuticals to raise US$7.9 million to fund its 12-month...November 1, 2023 | proactiveinvestors.com.auSMALL-CAP WINNERS & LOSERS: MGC Pharma drops on restructuring planSeptember 26, 2023 | lse.co.ukMGC Pharmaceuticals London Shares Fall on Restructuring PlanSeptember 26, 2023 | marketwatch.comMGC Pharmaceuticals proposes financial and capital restructuring planSeptember 26, 2023 | au.investing.com Get Argent BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MXC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MXC Media Mentions By Week MXC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MXC News Sentiment▼0.000.93▲Average Medical News Sentiment MXC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MXC Articles This Week▼00▲MXC Articles Average Week Get the Latest News and Ratings for MXC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Argent BioPharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies EOG News Today NOG News Today SUN News Today VAL News Today SHEL News Today BP News Today WDS News Today MRO News Today BPT News Today TTE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:MXC) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Argent BioPharma Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Argent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MXC Stock Alerts